This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Company. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Mark A Lyster: Innovator in Pharmaceutical Crystallization
Introduction
Mark A Lyster is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystal forms of compounds used in medical treatments.
Latest Patents
Lyster holds a patent for "Crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine." This invention relates to two novel crystal forms of a known compound, which are useful for treating individuals who are HIV positive. The crystal forms are identified by a powder X-ray diffraction spectrum known as the “S” and “T” forms. He has 1 patent to his name.
Career Highlights
Mark A Lyster is associated with Pharmacia & Upjohn Company, where he has contributed to various research and development projects. His work focuses on improving the efficacy and safety of pharmaceutical compounds through innovative crystallization techniques.
Collaborations
Lyster has collaborated with notable colleagues, including Donald P Smith and Michael S Bergren, to advance research in the pharmaceutical field.
Conclusion
Mark A Lyster's contributions to pharmaceutical innovations, particularly in the crystallization of compounds for HIV treatment, highlight his role as a significant inventor in the industry. His work continues to impact the field positively.